CVRx up on raising lower end of 2022 sales forecast range
** Medical device maker CVRx Inc's shares CVRX.O rise
12.7% to $8.51
** Co raises lower end of its 2022 sales forecast range to
$20.5 mln to $23 mln, vs prior outlook of between $20 mln and
$23 mln urn:newsml:reuters.com:*:nGNXbxCMkP
** Forecast raise follows a 90% increase in Q2 sales of its
heart failure device
** Including session gains, stock down ~30 YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on CVRx
See all newsBrief: CVRx Announces Humana Medicare Advantage Coverage Policy For Barostim Therapy
CVRx's Q1 revenue rises 20%, beats expectations
Brief: CVRx Q1 Revenue USD 14.769 Million Vs. IBES Estimate USD 14.5 Million
CVRx preliminary Q1 revenue rises 20%, gross margin improves
CVRx Q4 revenue rises 4%, beats expectations